Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407

Mazieres J., Kowalski D., Luft A., Vicente D., Tafreshi A., Gumus M. , ...More

43rd ESMO Congress (ESMO), Munich, Germany, 19 - 23 October 2018, vol.29 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 29
  • City: Munich
  • Country: Germany